Galván RE, Basurto L, Saucedo R, Campos S, Hernández M, Zárate A

Language: Spanish
References: 14
Page: 435-438
PDF size: 136.83 Kb.

ABSTRACT

Background: Adiponectin has a direct relationship with cellular sensibility grade to insulin action.
Objective: To determine adiponectin concentrations during the three phases of the menstrual cycle in young women, and to study the relationship with 17-β estradiol and progesterone levels.
Patient and methods: Longitudinal and prospective study that included 30 normal menstruating women aged between 19 and 36 years; none had received any hormonal therapy prior to this study. Adiponectin, 17-β estradiol, progesterone, LH and FSH were determined in blood in three phases of one menstrual cycle for each participant.
Results: Adiponectin concentrations were lower in the postovulatory phase as compared with the other two phases. Adiponectin levels did not significantly correlate with 17-β estradiol and progesterone.
Conclusion: Adiponectin blood levels are variable during the menstrual cycle, but the lower concentrations are observed in the postovulatory period that could be associated with other metabolic processes, such as insulin resistance.

REFERENCES

1. Ouchi N, Kihara S, Arita Y, Maeda K, et al. Novel modulator for endotelial adhesión molecules: adipocyte-derived plasma protein, adiponectin. Circulation 1999;100:2473-76.

2. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, et al. Circulating concentrations of the adypocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during Figura 1. La concentración de adiponectina es menor en la fase lútea del ciclo menstrual, sin que se observe diferencia entre las fases folicular y posovulatoria. progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-33.

3. Arita Y, Kihara S, Ouchi N, Takahashi M, et al. Paradoxical decrease of a adipose-specific protein, adiponectin, obesity. Biochem Biophys Res Commun 1999;257:79-83.

4. Hotta K, Funahashi T, Arita Y, Takahashi M, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-99.

5. Ardawi MS, Rouzii AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005;83:1708-16.

6. Sieminska L, Wojciechowska C, Foltyn W, Kajdaniuk D, et al. The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after menopause. Endokrynol Pol 2006;57:15-22.

7. Chu MC, Cosper P, Orio F, Carmina E, Lobo RA. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin and ghrelin. Am J Obstet Gynecol 2006;194:100-4.

8. Nishizawa H, Shimomura I, Kishida K, Maeda N, et al. Androgens decrease plasma adiponectin an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-41.

9. Kleiblova P, Springer D, Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiol Res 2006;55:661-66.

10. Combs TP, Berg AH, Rajala MW, Klevanov S, et al. Sexual differentiation, pregnancy, caloric restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003;52:268-76.

11. Saucedo R, Basurto L, Zarate A, Martinez C, et al. Effect of estrogen therapy on insulin resistance and plasminogen activator inhibitor type 1 concentration in postmenopausal women. Gynec Obstet Invest 2007; 64:61-64.

12. Zárate A, Saucedo R. Un análisis de la ubicación clínica del síndrome metabólico. Gac Med Méx 2006;142:27-30.

13. Zárate A, Saucedo R, Basurto L, Hernández M. Síndrome metabólico en la menopausia. En: Delgado UJ, Fernández del Castillo C. Ginecología y reproducción humana. Temas Selectos. Tomo II. México: Colegio Mexicano de Especialistas en Ginecología y Obstetricia, 2006;pp: 93-100.

14. Bruns CM, Kemnitz JW. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR J 2004;45:160-69.